List of Excipients in API bupivacaine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing bupivacaine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Renaissance Lakewood LLC | POSIMIR | bupivacaine | 49396-6601 | BENZYL ALCOHOL | |
| Renaissance Lakewood LLC | POSIMIR | bupivacaine | 49396-6601 | SUCROSE ACETATE ISOBUTYRATE | |
| INNOCOLL PHARMACEUTICALS | POSIMIR | bupivacaine | 51715-660 | BENZYL ALCOHOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing bupivacaine
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 | HYDROCHLORIC ACID |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 | METHYLPARABEN |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 | SODIUM CHLORIDE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for bupivacaine
Excipient focus: ANHYDROUS DEXTROSE
bupivacaine drug variants containing ANHYDROUS DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| B Braun Medical Inc | bupivacaine hydrochloride with dextrose | 0264-9379 |
| Hospira Inc | bupivacaine hydrochloride in dextrose | 0409-1761 |
| Hospira Inc | bupivacaine hydrochloride in dextrose | 0409-3613 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing ANHYDROUS DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: ASCORBIC ACID
bupivacaine drug variants containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | bupivacaine hydrochloride and epinephrine | 0409-5738 |
| Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-0557 |
| Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-9011 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: BENZYL ALCOHOL
bupivacaine drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci and epinephrine | 51662-1399 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
bupivacaine drug variants containing CITRIC ACID MONOHYDRATE
bupivacaine drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER
bupivacaine drug variants containing DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
| >Company | >Ingredient | >NDC |
Excipient focus: DEXTROSE
bupivacaine drug variants containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Brookfield Pharmaceuticals LLC | bupivacaine hydrochloride | 71351-022 |
| Huons Co Ltd | bupivacaine hydrochloride | 73293-0002 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHYL SULFOXIDE
bupivacaine drug variants containing DIMETHYL SULFOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing DIMETHYL SULFOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE CALCIUM DISODIUM
bupivacaine drug variants containing EDETATE CALCIUM DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-0557 |
| Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-9011 |
| Henry Schein Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0404-9908 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing EDETATE CALCIUM DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
bupivacaine drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci and epinephrine | 51662-1399 |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hcl | 51662-1592 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALEIC ACID
bupivacaine drug variants containing MALEIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing MALEIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
bupivacaine drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci and epinephrine | 51662-1399 |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hcl | 51662-1592 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: MONOTHIOGLYCEROL
bupivacaine drug variants containing MONOTHIOGLYCEROL
| Company | Ingredient | NDC |
|---|---|---|
| Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-0557 |
| Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-9011 |
| Henry Schein Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0404-9908 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing MONOTHIOGLYCEROL
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: NITROGEN
bupivacaine drug variants containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| Brookfield Pharmaceuticals LLC | bupivacaine hydrochloride | 71351-022 |
| Huons Co Ltd | bupivacaine hydrochloride | 73293-0002 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
bupivacaine drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci and epinephrine | 51662-1399 |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hcl | 51662-1592 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
bupivacaine drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci and epinephrine | 51662-1399 |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hcl | 51662-1592 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LACTATE
bupivacaine drug variants containing SODIUM LACTATE
| Company | Ingredient | NDC |
|---|---|---|
| Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-0557 |
| Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-9011 |
| Henry Schein Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0404-9908 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing SODIUM LACTATE
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM METABISULFITE
bupivacaine drug variants containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci and epinephrine | 51662-1399 |
| Hospira Inc | bupivacaine hydrochloride and epinephrine | 0409-5738 |
| Septodont Inc | bupivacaine hydrochloride and epinephrine bitartrate | 0362-0557 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE ACETATE ISOBUTYRATE
bupivacaine drug variants containing SUCROSE ACETATE ISOBUTYRATE
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing SUCROSE ACETATE ISOBUTYRATE
| Company | Ingredient | NDC |
|---|---|---|
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci and epinephrine | 51662-1399 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
bupivacaine drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
bupivacaine drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | bupivacaine hci | 51662-1581 |
| Hikma Pharmaceuticals USA Inc | bupivacaine hydrochloride | 0143-9328 |
| Hikma Pharmaceuticals USA Inc | bupivacaine hydrochloride | 0143-9330 |
| >Company | >Ingredient | >NDC |
bupivacaine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Renaissance Lakewood LLC | bupivacaine | 49396-6601 |
| INNOCOLL PHARMACEUTICALS | bupivacaine | 51715-660 |
| Heron Therapeutics Inc | bupivacaine and meloxicam | 47426-301 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
